Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medical Science and Technology/醫學科技學院
  3. School of Biomedical Sciences/生物醫學科學學系
  4. 利用細胞模式探討CLDN14基因突變造成非症候群聽障的致病機轉
 
  • Details
Options

利用細胞模式探討CLDN14基因突變造成非症候群聽障的致病機轉

Date Issued
2012
Author(s)
李東隆
Tung-Lung
Advisor
楊建洲
Jiann-Jou Yang  
URI
https://handle.ncl.edu.tw/11296/e67e4b
https://scholars.csmu.edu.tw/handle/123456789/5820
Abstract
人類CLAUDIN 14 (CLDN14) 基因的突變或缺失會造成非症候群性聽障 DFNB29 。在先前實驗室的研究中,從學齡前聽障患者找到幾個CLDN14的突變,這些突變包含了兩個錯意突變 : 52A>G/WT(M18V)與424G>A/WT(D142N),及一個核苷酸缺失造成的突變 : 167-168 delGG(W56S)。在先前實驗室已經成功篩選出CLDN14WT、CLDN14W56S 、CLDN14M18V、CLDN14D142N四株穩定表現的MDCK細胞株。本論文進一步利用細胞免疫螢光染色後觀察結果可以發現正常的CLDN14蛋白表現在細胞膜上且在MDCK細胞間形成緊密接合(tight junction),當CLDN14發生167-168delGG(W56S)的突變造成縮短的蛋白時,此突變蛋白均勻的分布在細胞質中。CLDN14M18V 的突變蛋白也無法形成緊密接合(tight junction),此突變蛋白是在靠近細胞膜的內緣形成堆積的蛋白,且有顯性負面效應(Dominant negative effect)的現象。更進一步的染色標定溶小體 (lysosome) 確認實際的表現位置發現CLDN14M18V與溶小體有共同表現的現象。利用溶小體抑制劑氯奎寧(chloroquine)作用於 CLDN14M18V–GFP 細胞株,在 mRNA 表現量不變的情況下,原本堆積在細胞內緣的 CLDN14M18V–GFP 蛋白質增多且蛋白質分子量下降。CLDN14D142N錯意突變的突變蛋白卻可以和正常CLAN14蛋白一樣被運送到細胞膜但緊密接合(tight junction)功能性是否正常仍然不清楚。藉由膜電阻值 (TER) 測定細胞緊密接合(Tight junction)的功能後發現除了CLDN14WT細胞株以外,其餘突變CLDN14W56S、CLDN14M18V、CLDN14D142N細胞株緊密接合(tight junction)的功能皆為異常。薑黃素(curcumin)可以降低內質網中鈣離子與不當摺疊蛋白間的結合力,進而減少蛋白酶體降解(Proteasomal degradation)的比例。以薑黃素作用後觀察CLDN14M18V細胞株的蛋白表現情形,以及利用蔗糖濃度梯度離心的方式分離細胞膜蛋白質,在薑黃素作用下 CLDN14M18V–GFP 蛋白質在細胞膜上的表現量有上升的趨勢,發現在薑黃素作用後 CLDN14M18V 細胞株的 CLDN14 蛋白會從細胞質轉移到細胞膜上,經過膜電阻值(TER)的測量,發現 CLDN14M18V 細胞株的緊密接合(tight junction)功能有被挽救的趨勢。以蛋白酶體抑制劑(MG132)作用於 CLDN14M18V–GFP 細胞株,隨著時間的增長CLDN14M18V–GFP 蛋白質表現於細胞膜上的比例有增多的趨勢,分離分離細胞膜蛋白質後分析結果,在處理蛋白酶體抑制劑(MG132)之後,CLDN14M18V–GFP 蛋白質與未加藥處理實驗控制組相比,CLDN14M18V–GFP 蛋白質在細胞膜上的表現比例增加了 7.76 倍。希望本論文研究成果能幫助探討非症候群聽障基因CLDN14 突變後的功能性分析、致病機轉,甚至是治療的方法。
The mutations or deletions of CLAUDIN 14 (CLDN14) gene are responsible for nonsyndromic deafness DFNB29 in human. Previously, we had identified 3 mutants of CLDN14 in prelingual nonsyndromic sensorineural deafness, including 2 missense mutations (M18V and D142N) and 1 deletion mutant (W56S). We had have 4 CLDN14 MDCK stable cell line including CLDN14WT, CLDN14M18V, CLDN14W56S and CLDN14D142N in the previous studies. In this study, our results indicated that CLDN14M18V and CLDN14W56S mutant proteins were accumulated and remained in the cytoplasm without being transferred to the plasma membrane. In addition, we found a dominant negative effect in CLDN14M18V mutant when co-transfection CLDN14WT and CLDN14M18V. Moreover, we found that CLDN14M18V proteins are co-localized with lysosome. Furtherlly, we found that the accumulated CLDN14M18V protein was increased without CLDN14 mRNA increased and the molecular size of accumulated CLDN14M18V protein was decreased after treating with chloroquine. In contrast, CLDN14D142N protein localized at the plasma membrane and in cytoplasmic compartment, similar to that of CLDN14WT protein. However, we found that CLDN14 D142N retained its ability in trafficking, but lost significantly its function as a barrier of tight junction in the transepithelial electrical resistance (TER) assay. In addition,the barrier function of tight junction is abnormal in CLDN14M18V, and CLDN14W56S MDCK cell line in transepithelial electrical resistance (TER) results. Curcumin inhibits a calcium pump (called sarcoplasmic reticulum Ca-ATPase) in the endoplasmic reticulum and decreases proteasomal degradation. In staining and compartmental protein extraction results, some part of accumulated CLDN14M18V protein was transferred to plasma membrane during treating with curcumin. Moreover, the barrier function of tight junction was rescued in CLDN14M18V cell line after treating with curcumin. A part of accumulated CLDN14M18V protein was also transferred to plasma membrane after treating with proteasome inhibitor, MG132, similar to curcumin treated. The CLDN14M18V expression rate in plasma membrane was increased about 7.76 fold compare to MG132 non-treated results. Base on these results, we hope this study could help us to learn more information of the functions, mechanisms or treatments in mutations or deletions of CLAUDIN 14 (CLDN14) gene.
Type
thesis
File(s)
No Thumbnail Available
Name

100CSMU5114011-001.zip

Size

6.02 MB

Format

Unknown

Checksum

(MD5):d7337efd69e7f4b83a091e160a2aa645

Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback